This company listing is no longer active
De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
5MP0 Overzicht aandelen
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 2/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 0/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Biodexa Pharmaceuticals Plc Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | UK£0.04 |
| 52 Week Hoogtepunt | UK£2.50 |
| 52 Week Laag | UK£0.01 |
| Bèta | 1.13 |
| 11 maand verandering | -76.71% |
| 3 maanden verandering | 304.00% |
| 1 Jaar Verandering | -98.38% |
| 33 jaar verandering | -99.40% |
| 5 jaar verandering | -99.97% |
| Verandering sinds IPO | -99.99% |
Recent nieuws en updates
Recent updates
Rendement voor aandeelhouders
| 5MP0 | DE Biotechs | DE Markt | |
|---|---|---|---|
| 7D | -17.2% | 0.7% | 1.1% |
| 1Y | -98.4% | -8.5% | 18.9% |
Rendement versus industrie: 5MP0 underperformed the German Biotechs industry which returned -7% over the past year.
Rendement versus markt: 5MP0 underperformed the German Market which returned 5.9% over the past year.
Prijsvolatiliteit
| 5MP0 volatility | |
|---|---|
| 5MP0 Average Weekly Movement | 542.1% |
| Biotechs Industry Average Movement | 6.4% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiele aandelenkoers: 5MP0's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: 5MP0's weekly volatility has increased from 321% to 542% over the past year.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2000 | 20 | Stephen Stamp | www.biodexapharma.com |
Biodexa Pharmaceuticals Plc Samenvatting
| 5MP0 fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | €4.01m |
| Inkomsten(TTM) | -€6.06m |
| Inkomsten(TTM) | €728.56k |
5.5x
P/S-verhouding-0.7x
Koers/WinstverhoudingIs 5MP0 overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| 5MP0 resultatenrekening (TTM) | |
|---|---|
| Inkomsten | UK£645.00k |
| Kosten van inkomsten | UK£4.65m |
| Brutowinst | -UK£4.01m |
| Overige uitgaven | UK£1.36m |
| Inkomsten | -UK£5.37m |
Laatst gerapporteerde inkomsten
Jun 30, 2022
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | -0.057 |
| Brutomarge | -621.55% |
| Nettowinstmarge | -832.09% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde 5MP0 op de lange termijn?
Bekijk historische prestaties en vergelijking